Peptides may have a lot of untapped potential, but online, theyre advertised for uses far beyond what the science has actually found such as reducing wrinkles, boosting muscle growth and improving sleep and libido.Justine Goode / NBC News
Apply once daily rather than twice
A licensed provider reviews your information to determine eligibility

BPC-157/TB-500 10+10mg $160.00 Volume discounts Auto-applied at checkout Free shipping on orders of $200+ Compound Identity COMPOUND NAME BPC-157 and TB-500 peptide blend SYNONYMS Body Protection Compound-157 (BPC-157), Thymosin Beta-4 Fragment (TB-500) CAS NUMBER BPC-157: 137525-51-0 TB-500: 77591-33-4 MOLECULAR FORMULA BPC-157: C 62 H 98 N 16 O 22 TB-500: C 212 H 350 N 56 O 78 S MOLECULAR WEIGHT BPC-157: 1419.53552 g/mol TB-500: ~4963.49 g/mol STRUCTURE Synthetic tetrapeptide PEPTIDE SEQUENCE BPC-157: Gly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val TB-500: Ac-Ser-Asp-Lys-Pro-Asp-Met-Ala-Glu-Ile-Glu-Lys-Phe-Lys-Asp-Lys-Ser-Ile-Lys-Asn-Asp-Lys-Pro-Thr CHEMICAL STRUCTURE BPC-157: TB-500: CHEMICAL STRUCTURE BPC-157: C 62 H 98 N 16 O 22 TB-500: C 212 H 350 N 56 O 78 S Mechanism of Action BPC-157 is believed to act via modulation of nitric oxide pathways, angiogenesis induction, and cytoprotective effects through VEGFR-2 and FAK-paxillin pathways

Not for human or veterinary consumption, and not for diagnostic, therapeutic, clinical or drug use
After consideration of public comments, we are finalizing our proposal without modification that an ( ASM participant must comply with reporting requirements for each measure at 512.740(b)(3)(i) and report on the Promoting Interoperability objective and measures specified by CMS to assess performance in the Promoting Interoperability ASM performance category at 512.740(b)(2), including the objectives and measures at 512.740(b)(2)(i) through (iv): Electronic Prescribing, HIE, Provider to Patient Exchange, and Public Health and Clinical Data Exchange